Table 2.
Year | Male | Females | Overall | |||
Tests <1000 copies/mL N (%) | Individuals with VL <1000 copies/mL N (%) | Tests <1000 copies/mL N (%) | Individuals with VL <1000 copies/mL N (%) | Tests <1000 copies/mL N (%) | Individuals with VL <1000 copies/mL N (%) | |
2008 | 14 557 (83.5) | 10 738 (84.1) | 28 696 (85.1) | 21 297 (86.2) | 43 253 (84.6) | 32 035 (85.5) |
2009 | 26 973 (84.7) | 16 663 (84.4) | 53 850 (86.6) | 32 789 (86.7) | 80 823 (85.9) | 49 452 (85.9) |
2010 | 26 578 (83.8) | 19 797 (85.2) | 52 017 (84.6) | 38 813 (86.3) | 78 595 (84.3) | 58 610 (85.9) |
2011 | 33 756 (78.9) | 26 907 (83.7) | 67 789 (79.9) | 53 992 (85.2) | 101 545 (79.6) | 80 899 (84.7) |
2012 | 41 971(81) | 34 263 (85.3) | 85 985 (82.9) | 69 903 (87.5) | 127 956 (82.3) | 104 166 (86.7) |
2013 | 50 801 (80.9) | 41 138 (85.6) | 104 750 (82.6) | 85 690 (87.5) | 155 551 (82.1) | 126 828 (86.9) |
2014 | 52 128 (81.1) | 44 108 (85.7) | 115 523 (83.9) | 96 100 (88.1) | 167 651(83) | 140 208 (87.3) |
2015 | 61 358 (82.2) | 52 614 (86.5) | 142 353 (85.4) | 117 255 (89.2) | 203 711 (84.4) | 169 869 (88.3) |
2016 | 72 922(83) | 62 655 (87.9) | 166 176 (85.7) | 135 684(90) | 239 098 (84.9) | 198 339 (89.3) |
2017 | 79 031 (83.5) | 69 454 (88.3) | 183 101 (86.6) | 152 080 (90.7) | 262 132 (85.7) | 221 534 (89.9) |
2018* | 64 195(85) | 60 726 (88.6) | 147 576 (87.7) | 133 768 (90.7) | 211 771 (86.9) | 194 494(90) |
*2018 is a partial year estimate, January to September.
VL, viral load.